[PDF][PDF] Changes in Hepatitis C Virus Reinfection Incidence Associated with Access to Direct-Acting Antiviral Therapies in People with HIV from Six Countries, 2010 …
Approximately 58 million people live with hepatitis C virus (HCV), 1 which causes an
estimated 290,000 annual deaths. 2 In 2013, highly effective (≥ 95%) direct-acting antiviral
(DAA) therapies revolutionised HCV treatment. 3 In 2016, this led the World Health
Organization (WHO) to set ambitious targets to eliminate HCV as a public health threat.
Global targets include reducing incidence by 30% in 2020 and by 80% in 2030 (vs. 2015). 4
HCV infection is more common among people with HIV (PHIV) than individuals without HIV …
estimated 290,000 annual deaths. 2 In 2013, highly effective (≥ 95%) direct-acting antiviral
(DAA) therapies revolutionised HCV treatment. 3 In 2016, this led the World Health
Organization (WHO) to set ambitious targets to eliminate HCV as a public health threat.
Global targets include reducing incidence by 30% in 2020 and by 80% in 2030 (vs. 2015). 4
HCV infection is more common among people with HIV (PHIV) than individuals without HIV …
以上显示的是最相近的搜索结果。 查看全部搜索结果